Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment

John H. Phan, Richard A. Moffitt, Todd H. Stokes, Jian Liu, Andrew N. Young, Shuming Nie, May D. Wang

Research output: Contribution to journalReview article

Abstract

Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual's molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.

Original languageEnglish (US)
Pages (from-to)350-358
Number of pages9
JournalTrends in Biotechnology
Volume27
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Nanotechnology
Oncology
Biomarkers
Bioinformatics
Tumor Biomarkers
Computational Biology
Precision Medicine
Medicine
Nanoparticles
Disease Progression
Molecular Biology
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering

Cite this

Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. / Phan, John H.; Moffitt, Richard A.; Stokes, Todd H.; Liu, Jian; Young, Andrew N.; Nie, Shuming; Wang, May D.

In: Trends in Biotechnology, Vol. 27, No. 6, 01.06.2009, p. 350-358.

Research output: Contribution to journalReview article

Phan, John H. ; Moffitt, Richard A. ; Stokes, Todd H. ; Liu, Jian ; Young, Andrew N. ; Nie, Shuming ; Wang, May D. / Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. In: Trends in Biotechnology. 2009 ; Vol. 27, No. 6. pp. 350-358.
@article{46e143e969734917a32afe54ee691c03,
title = "Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment",
abstract = "Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual's molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.",
author = "Phan, {John H.} and Moffitt, {Richard A.} and Stokes, {Todd H.} and Jian Liu and Young, {Andrew N.} and Shuming Nie and Wang, {May D.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.tibtech.2009.02.010",
language = "English (US)",
volume = "27",
pages = "350--358",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment

AU - Phan, John H.

AU - Moffitt, Richard A.

AU - Stokes, Todd H.

AU - Liu, Jian

AU - Young, Andrew N.

AU - Nie, Shuming

AU - Wang, May D.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual's molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.

AB - Recent advances in biomarker discovery, biocomputing and nanotechnology have raised new opportunities in the emerging fields of personalized medicine (in which disease detection, diagnosis and therapy are tailored to each individual's molecular profile) and predictive medicine (in which genetic and molecular information is used to predict disease development, progression and clinical outcome). Here, we discuss advanced biocomputing tools for cancer biomarker discovery and multiplexed nanoparticle probes for cancer biomarker profiling, in addition to the prospects for and challenges involved in correlating biomolecular signatures with clinical outcome. This bio-nano-info convergence holds great promise for molecular diagnosis and individualized therapy of cancer and other human diseases.

UR - http://www.scopus.com/inward/record.url?scp=65549115157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549115157&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2009.02.010

DO - 10.1016/j.tibtech.2009.02.010

M3 - Review article

C2 - 19409634

AN - SCOPUS:65549115157

VL - 27

SP - 350

EP - 358

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 6

ER -